Bio-Rad Laboratories Inc (NYSE:BIO.B)
$ 365.08 (0%) Market Cap: 9.84 Bil Enterprise Value: 9.59 Bil PE Ratio: 44.70 PB Ratio: 1.37 GF Score: 70/100

Bio-Rad Laboratories, Inc. at Wells Fargo Healthcare Conference Transcript

Sep 9, 2026 / 07:45 PM GMT
Release Date Price: $365.08


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BIO.N - Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. at Wells Fargo Healthcare Conference
Sep 09, 2026 / 07:45PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
So this is the last meeting today for Life Sciences, Tools and Diagnostics. Thanks everyone for being here.

We have Biorad, CFO Roop Lakharaju.

Thank you for being here.

Maybe the best place to start, 2Q, organic growth minus 2% ahead of consensus.

X processed Chrome, I think you were flat.

So can you kind of walk us through what got better in 2Q, what remains below plan? And then, from an end market perspective, where have trends improved the most over the last six, 12 months, like A&G, biotech, biopharma, et cetera? Very good.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot